dactinomycin has been researched along with epirubicin in 25 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (32.00) | 18.2507 |
| 2000's | 8 (32.00) | 29.6817 |
| 2010's | 9 (36.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ | 1 |
| Ekins, S; Williams, AJ; Xu, JJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Alfonso, A; Arnaez, E; Botana, LM; Louzao, MC; Vieytes, MR | 1 |
| Cold, S; Pfeiffer, P; Rose, C | 1 |
| Bachy, B; Caillaud, JM; Flamant, F; Gruner, M; Hemet, J; Lefur, R; Lemerle, J; Tron, P; Vannier, JP | 1 |
| Bayley, AC | 1 |
| Akyüz, C; Berberoğlu, S; Büyükpamukçu, M | 1 |
| Bladou, F; Delpero, JR; Merrot, T; Moutardier, V; Viens, P | 1 |
| Carli, M; Colombatti, R; Frascella, E; Koscielniak, E; Masiero, L; Oberlin, O; Pinkerton, CR; Stevens, M; Treuner, J | 1 |
| Bekradda, M; Bensmaïne, MA; Brain, E; Cvitkovic, E; Di Palma, M; Garrino, C; Goupil, A; Misset, JL; Soulié, P | 1 |
| Bouvet, N; Ellershaw, C; Flamant, F; Habrand, JL; Marsden, HB; Martelli, H; Oberlin, O; Rey, A; Sanchez de Toledo, J; Spicer, RD; Spooner, D; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A | 1 |
| Abelairas Gómez, JM; Calvo, JM; Olivier Pascual, N | 1 |
| Oberlin, O; Orbach, D; Quintana, E; Rey, A; Sanchez de Toledo, J; Stevens, MC; Terrier-Lacombe, MJ; van Unnik, A | 1 |
| Bisogno, G; Casale, F; Cecchetto, G; De Salvo, G; Di Martino, M; Di Tullio, MT; Donfrancesco, A; Donofrio, V; Ferrari, A; Indolfi, P; Martone, A | 1 |
| Huang, Y; Li, MJ; Liang, JF; Tang, DX; Tang, HF; Zhou, YB | 1 |
| Beske, F; Boos, J; Dantonello, T; Gadner, H; Hallmen, E; Int-Veen, C; Kazanowska, B; Klingebiel, T; Koscielniak, E; Marky, I; Treuner, J | 1 |
| Affolter, A; Ahmed, M; Marais, R; Nutting, CM; Pritchard-Jones, K; Sharma, AK; Thomas, V; Venkitaraman, R | 1 |
| De Kraker, J; Dijkgraaf, MG; Heij, H; Jagt, CT; Taminiau, JA; Ten Kate, F; Verschuur, AC; Zuckermann, M | 1 |
| Anderson, JR; Dasgupta, R; Gupta, AA; Hawkins, DS; Indelicato, DJ; Pappo, AS; Spunt, SL | 1 |
| Bergeron, C; Bouvet, N; Ellershaw, C; Jenney, ME; Kelsey, A; Martelli, H; Merks, JH; Oberlin, O; Rey, A; Sanchez de Toledo, J; Scopinaro, M; Spooner, D; Stevens, MC | 1 |
| Amesty, MV; Chenu, BG; Chocarro, G; Gámez, M; Hernández, F; Hernández, S; Ortíz, R; Sánchez, A; Santamaría, ML; Tovar, JA | 1 |
| Boutroux, H; Cellier, C; Desjardins, L; Freneaux, P; Helfre, S; Levy, C; Michon, J; Mosseri, V; Orbach, D; Plancher, C | 1 |
| Adamkiewicz-Drozynska, E; Bien, E; Fatyga, A; Gabrych, A; Izycka-Swieszewska, E; Kazanowska, B; Krawczyk, MA; Kunc, M; Sokolewicz, EM; Styczewska, M | 1 |
3 review(s) available for dactinomycin and epirubicin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Cytotoxic treatment of metastatic breast cancer. Which drugs and drug combinations to use?
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Fluorouracil; Humans; Melphalan; Methotrexate; Mitomycin; Mitoxantrone; Neoplasm Metastasis; Vincristine | 1992 |
[Orbital rhabdomyosarcoma: difficulties with European treatment protocol].
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Clinical Protocols; Combined Modality Therapy; Cranial Irradiation; Dactinomycin; Disease-Free Survival; Epirubicin; Etoposide; Eye Enucleation; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Life Tables; Male; Neoplasm Recurrence, Local; Neoplasm Staging; Orbital Neoplasms; Radiation Injuries; Radiotherapy, Adjuvant; Reoperation; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vincristine | 2005 |
7 trial(s) available for dactinomycin and epirubicin
| Article | Year |
|---|---|
Occurrence, clinical behaviour and management of Kaposi's sarcoma in Zambia.
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Dactinomycin; Delivery of Health Care; Drug Evaluation; Epirubicin; Female; Humans; Incidence; Male; Neoplasm Staging; Prognosis; Quality of Health Care; Sarcoma, Kaposi; Skin Neoplasms; Vincristine; Zambia | 1991 |
High-dose melphalan with autologous stem-cell rescue in metastatic rhabdomyosarcoma.
Topics: Adolescent; Antineoplastic Agents, Alkylating; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Carboplatin; Cell Transplantation; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Epirubicin; Humans; Ifosfamide; Infant; Melphalan; Prospective Studies; Rhabdomyosarcoma; Treatment Outcome; Vincristine | 1999 |
Antitumoral activity of oxaliplatin/cisplatin-based combination therapy in cisplatin-refractory germ cell cancer patients.
Topics: Adolescent; Adult; alpha-Fetoproteins; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Chorionic Gonadotropin, beta Subunit, Human; Cisplatin; Dactinomycin; Drug Resistance, Neoplasm; Drug Therapy, Combination; Epirubicin; Etoposide; Germinoma; Humans; Ifosfamide; Male; Neoplasm Recurrence, Local; Neutropenia; Organoplatinum Compounds; Oxaliplatin; Salvage Therapy; Testicular Neoplasms; Thrombocytopenia; Treatment Outcome; Vinblastine; Vinorelbine | 1999 |
Treatment of nonmetastatic rhabdomyosarcoma in childhood and adolescence: third study of the International Society of Paediatric Oncology--SIOP Malignant Mesenchymal Tumor 89.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dactinomycin; Disease-Free Survival; Drug Administration Schedule; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Infant; Infant, Newborn; Male; Multivariate Analysis; Neoplasm Recurrence, Local; Neoplasm Staging; Prognosis; Rhabdomyosarcoma; Teniposide; Treatment Outcome; Vincristine | 2005 |
Soft tissue sarcoma or malignant mesenchymal tumors in the first year of life: experience of the International Society of Pediatric Oncology (SIOP) Malignant Mesenchymal Tumor Committee.
Topics: Age Factors; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Infant, Newborn; Neoplasm Metastasis; Neoplasm Recurrence, Local; Rhabdomyosarcoma; Sarcoma; Survival Analysis; Teniposide; Vincristine | 2005 |
Treatment of children with metastatic soft tissue sarcoma with oral maintenance compared to high dose chemotherapy: report of the HD CWS-96 trial.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Idarubicin; Ifosfamide; Infant; Kaplan-Meier Estimate; Male; Melphalan; Sarcoma; Soft Tissue Neoplasms; Thiotepa; Treatment Outcome; Vincristine | 2008 |
Randomized comparison of intensified six-drug versus standard three-drug chemotherapy for high-risk nonmetastatic rhabdomyosarcoma and other chemotherapy-sensitive childhood soft tissue sarcomas: long-term results from the International Society of Pediatr
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Dactinomycin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Male; Prognosis; Rhabdomyosarcoma; Sarcoma; Treatment Outcome; Vincristine | 2012 |
15 other study(ies) available for dactinomycin and epirubicin
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Developing structure-activity relationships for the prediction of hepatotoxicity.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes | 2010 |
A predictive ligand-based Bayesian model for human drug-induced liver injury.
Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands | 2010 |
Nonimmunological release of histamine from rat mast cells elicited by antineoplastic agents: effect of drug combinations.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Calcium; Dactinomycin; Daunorubicin; Doxorubicin; Epirubicin; Histamine Release; Mast Cells; p-Methoxy-N-methylphenethylamine; Peritoneal Cavity; Pleura; Rats; Rats, Sprague-Dawley | 1992 |
Pancreatoblastoma: response to chemotherapy.
Topics: Adenocarcinoma; Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Child; Child, Preschool; Cisplatin; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Etoposide; Female; Humans; Ifosfamide; Lymphatic Metastasis; Male; Pancreatic Neoplasms; Vinblastine; Vincristine | 1991 |
Successful treatment of intracaval and atrial extension of Wilms' tumour by chemotherapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Combined Modality Therapy; Dactinomycin; Epirubicin; Heart Atria; Humans; Kidney Neoplasms; Male; Neoplasm Invasiveness; Vena Cava, Inferior; Vincristine; Wilms Tumor | 1996 |
[Drug-resistant genito-urinary rhabdomyosarcoma in children with primary psoas abscess. Apropos of a case].
Topics: Adolescent; Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Dactinomycin; Drug Resistance, Neoplasm; Epirubicin; Humans; Ifosfamide; Male; Pelvic Neoplasms; Psoas Abscess; Rhabdomyosarcoma, Embryonal; Vincristine | 1997 |
Prognostic factors in pleuro-pulmonary blastoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease Progression; Disease-Free Survival; Doxorubicin; Epirubicin; Etoposide; Female; Follow-Up Studies; Humans; Ifosfamide; Infant; Kaplan-Meier Estimate; Lung Neoplasms; Male; Neoplasm Metastasis; Neoplasm Staging; Pleural Neoplasms; Pneumonectomy; Prognosis; Pulmonary Blastoma; Radiotherapy, Adjuvant; Retrospective Studies; Risk Factors; Second-Look Surgery; Treatment Outcome; Vincristine | 2007 |
[Treatment of advanced Wilms' tumor].
Topics: Antineoplastic Combined Chemotherapy Protocols; Chemoembolization, Therapeutic; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Disease-Free Survival; Epirubicin; Female; Follow-Up Studies; Humans; Infant; Iodized Oil; Kidney Neoplasms; Male; Neoplasm Staging; Nephrectomy; Preoperative Care; Survival Rate; Treatment Outcome; Vincristine; Wilms Tumor | 2006 |
Childhood papillary thyroid cancer as second malignancy after successful treatment of rhabdomyosarcoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Papillary; Combined Modality Therapy; Dactinomycin; DNA, Neoplasm; Epirubicin; Etoposide; Humans; Ifosfamide; Infant; Iodine Radioisotopes; Male; Neoplasms, Second Primary; Rhabdomyosarcoma, Embryonal; Spinal Neoplasms; Thoracic Vertebrae; Thyroid Neoplasms; Thyroidectomy; Vincristine | 2008 |
Veno-occlusive disease as a complication of preoperative chemotherapy for Wilms tumor: A clinico-pathological analysis.
Topics: Alanine Transaminase; Antineoplastic Combined Chemotherapy Protocols; Aspartate Aminotransferases; Chemotherapy, Adjuvant; Child; Child, Preschool; Dactinomycin; Doxorubicin; Epirubicin; Female; Hepatic Veno-Occlusive Disease; Humans; Incidence; Infant; Kidney Neoplasms; Liver; Male; Neoadjuvant Therapy; Nephrectomy; Postoperative Complications; Retrospective Studies; Ultrasonography; Wilms Tumor | 2009 |
Patterns of chemotherapy-induced toxicities in younger children and adolescents with rhabdomyosarcoma: a report from the Children's Oncology Group Soft Tissue Sarcoma Committee.
Topics: Adolescent; Age Factors; Anemia; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Incidence; Male; Mesna; Neutropenia; Rhabdomyosarcoma; Sex Characteristics; Survival Rate; Thrombocytopenia; Vincristine; Young Adult | 2012 |
Embryonal sarcoma of the liver.
Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Combined Modality Therapy; Dactinomycin; Doxorubicin; Epirubicin; Female; Humans; Ifosfamide; Infant; Liver; Liver Neoplasms; Male; Retrospective Studies; Sarcoma; Survival Analysis; Treatment Outcome; Vincristine | 2013 |
Orbital rhabdomyosarcoma in children: a favorable primary suitable for a less-invasive treatment strategy.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Chemoradiotherapy; Child; Child, Preschool; Cyclophosphamide; Dactinomycin; Disease-Free Survival; Epirubicin; Follow-Up Studies; Humans; Ifosfamide; Infant; Neoplasm Staging; Orbital Neoplasms; Prognosis; Radionuclide Imaging; Retrospective Studies; Rhabdomyosarcoma; Treatment Outcome; Vincristine; Young Adult | 2014 |
Tumour expressions of hypoxic markers predict the response to neo-adjuvant chemotherapy in children with inoperable rhabdomyosarcoma.
Topics: Adolescent; Antigens, Neoplasm; Biomarkers, Tumor; Biopsy; Carbonic Anhydrase IX; Carboplatin; Chemotherapy, Adjuvant; Child; Child, Preschool; Dactinomycin; Epirubicin; Female; Gene Expression; Glucose Transporter Type 1; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Ifosfamide; Infant; Infant, Newborn; Male; Muscle Neoplasms; Neoadjuvant Therapy; Prognosis; Prospective Studies; Rhabdomyosarcoma, Alveolar; Rhabdomyosarcoma, Embryonal; Survival Analysis; Treatment Outcome; Vascular Endothelial Growth Factor A; Vincristine | 2019 |